Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,48 USD | -1,97% |
|
+9,78% | -52,33% |
Attività
Numero di dipendenti: 179
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Precision Oncology Drugs
100,0
%
| 132 | 100,0 % | 51 | 100,0 % | -61,21% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
51,1
%
| 15 | 11,5 % | 26 | 51,1 % | +71,71% |
Switzerland
28,4
%
| 117 | 88,5 % | 15 | 28,4 % | -87,56% |
Japan
20,5
%
| - | - | 11 | 20,5 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Lloyd Segal
CEO | Chief Executive Officer | 60 | 01/06/16 |
Steve Forte
DFI | Director of Finance/CFO | 45 | 01/10/19 |
Michael Zinda
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/05/19 |
Maria Koehler
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/05/19 |
Robin T. Garner
IRC | Investor Relations Contact | - | - |
Daniel Bélanger
HRO | Human Resources Officer | - | 09/05/23 |
Philip Herman
PRN | Corporate Officer/Principal | - | 05/01/22 |
Kim Seth
PRN | Corporate Officer/Principal | - | 01/06/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 01/03/19 |
Lloyd Segal
CEO | Chief Executive Officer | 60 | 01/06/16 |
Ann Rhoads
BRD | Director/Board Member | 58 | 10/06/20 |
David Bonita
BRD | Director/Board Member | 48 | 01/09/19 |
Susan Molineaux
BRD | Director/Board Member | 70 | 08/06/23 |
Briggs Morrison
BRD | Director/Board Member | 65 | 01/06/17 |
Thomas Civik
CHM | Chairman | 55 | 07/09/21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 01/11/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 42 445 406 | 42 027 846 ( 99,02 %) | 0 | 99,02 % |
Coordinate società
Repare Therapeutics, Inc.
7171 Frederick-Banting Suite 270
H4S 1Z9, Saint-Laurent
+
http://www.reparerx.com![Indirizzo Repare Therapeutics Inc.(RPTX)](https://cdn.zonebourse.com/static/address/108596811.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-52,33% | 151 Mln | |
+22,10% | 47,07 Mrd | |
+46,45% | 42,06 Mrd | |
-3,12% | 39,98 Mrd | |
+36,10% | 33,02 Mrd | |
-6,30% | 27,9 Mrd | |
+18,71% | 27,63 Mrd | |
+46,15% | 14,37 Mrd | |
+44,52% | 13,45 Mrd | |
+0,19% | 12,03 Mrd |
- Borsa valori
- Azioni
- Azione RPTX
- Società Repare Therapeutics Inc.